4ABio
 |
||
4A is a biotech company focused on activities related to the antibodies. 4A Biotech has developed ranges of ELISA kits and hundreds of monoclonal antibodies against cancer (particularly leukemia) as well as products for immunology research base. | ||
SARS-CoV-2 - Antibodies for research and development
The ongoing COVID-19 pandemic has sickened over 520,000 people worldwide. There is an urgent need to increase the current diagnosis capacity. Compared with the commonly-used PCR testing, serological assay-based diagnostic method is much easier and faster to perform. To support the development of immunodiagnostic methods, we offer a complete collection of antibodies and antigens for SARS-CoV-2.
We other both primary and secondary antibodies for detection and diagnostic tools development :
- Primary antibodies against the 2 main protein of SARS-CoV-2 : Nucleocapsid protein (N protein) and Spike protein (S protein)
- Secondary antibodies against human IgG and IgM antibodies in order to detect the anti-SARS-CoV-2 in patient samples
These antibodies can be used to quantify antigens on the surface of SARS-CoV-2 (or antigens expressed recombinantly) or anti-SARS-CoV-2 antibodies in patient samples.
